Cafepharma Today

May 21 2025 - Medtronic plans to separate its diabetes business into a new company
Medtronic plans to separate its diabetes business into a new company
Moderna shares down after pulling Covid-flu combo vaccine application
Roche's Genentech sticks with Orionis in 2nd molecular glue deal worth $2B
RFK Jr. takes fire in Senate hearing on research cuts
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Novo Nordisk Sees Lower U.S. Price Increases Amid Health Reform
Bloomberg
Thursday, May 5, 2011 - 7:33am
tags:
healthcare reform, Novo Nordisk
Ranbaxy Falls Most in 6 Weeks After $1 Billion Fines Report
Bloomberg
Thursday, May 5, 2011 - 7:31am
tags:
Ranbaxy, India, Daiichi Sankyo
Evidence For Abilify & Bipolar Disorder Is Debated
Pharmalot
Wednesday, May 4, 2011 - 8:53pm
tags:
Abilify, bipolar disorder, Bristol-Myers Squibb
Cell Therapeutics: Denied but Not Rejected
Motley Fool
Wednesday, May 4, 2011 - 8:50pm
tags:
Cell Therapeutics, pixantrone, FDA
Adventrx Poised for Run-Up Before FDA Decision
Seeking Alpha
Wednesday, May 4, 2011 - 8:48pm
tags:
Adventrx, FDA, Exelbine
Ariad Pharma books bigger 1Q loss on charge
Yahoo/AP
Wednesday, May 4, 2011 - 8:46pm
tags:
Ariad Pharmaceuticals, earnings
Allergan licenses retinal disease treatment from Molecular Partners in $420 million deal
Yahoo/AP
Wednesday, May 4, 2011 - 8:45pm
tags:
Allergan, Molecular Partners, retinal disease
Merck Serono pays $44M to settle kickback charge
Yahoo/AP
Wednesday, May 4, 2011 - 8:44pm
tags:
Merck Serono, settlements, kickbacks, Rebif
Teva And Cephalon Solve Each Other's Problems
Investopedia
Wednesday, May 4, 2011 - 8:41pm
tags:
Teva Pharmaceuticals, Cephalon, M&A
Spectrum Pharma: Zevalin Bubble Deflates
TheStreet.com
Wednesday, May 4, 2011 - 12:37pm
tags:
Zevalin, Spectrum Pharmaceuticals, non-Hodgkin's lymphoma
Must Read: From Glivec To Medivation
Forbes
Wednesday, May 4, 2011 - 12:35pm
tags:
Glivec, Medivation, prostate cancer, MDV3100
Should Drugmakers Sell ‘Non-Pharma’ Businesses?
Pharmalot
Wednesday, May 4, 2011 - 11:45am
tags:
Pfizer, reorganization
Moody's: Pharma sell-offs put credit ratings at risk
Fierce Pharma
Wednesday, May 4, 2011 - 11:34am
tags:
credit rating
Amgen: 4 Factors That Should Boost Stock
Seeking Alpha
Wednesday, May 4, 2011 - 11:25am
tags:
Amgen
Onyx Pharma 1Q loss grows as expenses rise
Yahoo/AP
Wednesday, May 4, 2011 - 11:24am
tags:
earnings, ONYX Pharmaceuticals
Lannett Awaits 3 Expected FDA Decisions
Seeking Alpha
Wednesday, May 4, 2011 - 11:24am
tags:
FDA, Lannett
Allergan reports lower profit
Marketwatch
Wednesday, May 4, 2011 - 11:14am
tags:
Allergan, earnings
Charles River Labs 1st-quarter profit surges on sale of early-stage business, but revenue dips
Yahoo/AP
Wednesday, May 4, 2011 - 9:58am
tags:
earnings, Charles River Laboratories
Exelixis' CEO Discusses Q1 2011 Results - Earnings Call Transcript
Seeking Alpha
Wednesday, May 4, 2011 - 9:57am
tags:
earnings, Exelixis
FTC Complains Pay-To-Delay Deals ‘Skyrocketed’
Pharmalot
Wednesday, May 4, 2011 - 9:55am
tags:
FTC, pay-for-delay, generics

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.